Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producer cells assists de novo infection by enhancing viral gene expression

Masahiro Yaguchi, Yoshitaka Sato, Yusuke Okuno, Takayuki Murata, Somi Ozaki, Takeshi Suzuki, Tomoki Inagaki, Takahiro Watanabe, Hiroshi Kimura

Research output: Contribution to journalArticlepeer-review

Abstract

Viruses must adapt to the environment of their host cells to establish infection and persist. Diverse mammalian cells, including virus-infected cells, secrete extracellular vesicles such as exosomes containing proteins and miRNAs. These vesicles mediate intercellular communications, suggesting that they modulate viral infection by adapting cellular conditions. However, the roles of exosomes in viral infection remain unclear. Here we screened viral proteins to identify those responsible for the exosome-mediated upregulation of Epstein-Barr virus (EBV) infection. We found BGLF2 protein encapsulated in exosomes, which enhanced the EBV infection of Akata(-) B-cells. BGLF2 protein is a tegument protein that lines the space between the envelope and the nucleocapsid, and it is released shortly after infection into the cytoplasm. Therefore, tegument protein BGLF2 is encapsulated not only in viral particles, but also in exosomes secreted from infected cells, and plays crucial roles in establishing the EBV latent infection by modulating the cellular environment.

Original languageEnglish
JournalUnknown Journal
DOIs
Publication statusPublished - 23-06-2020

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producer cells assists de novo infection by enhancing viral gene expression'. Together they form a unique fingerprint.

Cite this